» Articles » PMID: 16268967

Prevalence and Demographics of Irritable Bowel Syndrome: Results from a Large Web-based Survey

Overview
Date 2005 Nov 5
PMID 16268967
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Irritable bowel syndrome is a common gastrointestinal disorder, and its prevalence and demographics have been evaluated by different methodologies with varying results.

Aim: To evaluate irritable bowel syndrome demographic and prevalence characteristics utilizing a web-enabled panel.

Methods: From an existing 150 000-member panel, 31 829 individuals were randomly selected and sent screening questionnaires to evaluate irritable bowel syndrome symptoms. Individuals who agreed to participate and completed the screening questionnaire received a second questionnaire related to a diagnosis of irritable bowel syndrome, a more detailed symptom description, and additional burden of illness data.

Results: Irritable bowel syndrome prevalence was 7%. Prevalence was higher in women vs. men, unmarried individuals vs. married individuals and unemployed individuals vs. employed individuals. Of those completing the second questionnaire, 51% had seen their physicians for irritable bowel syndrome symptoms in the past year and most had an episode within the past 3 months. During the past year, approximately half of the participants had used a prescription medication, and over 90% had used an over-the-counter medication for irritable bowel syndrome. Participants with irritable bowel syndrome demonstrated quality-of-life reductions relative to norms of the United States population.

Conclusions: Web-enabled data collection represents a novel tool for rapidly surveying a large population of individuals with irritable bowel syndrome symptoms.

Citing Articles

Factors Associated With the Prevalence of Irritable Bowel Syndrome: The Miyagi Part of the Tohoku Medical Megabank Project Community-based Cohort Study.

Nakaya K, Nakaya N, Kogure M, Hatanaka R, Chiba I, Kanno I J Neurogastroenterol Motil. 2024; 30(2):208-219.

PMID: 38576370 PMC: 10999836. DOI: 10.5056/jnm23090.


Translation, validation, and first application of the Greek version of an irritable bowel syndrome severity scoring system.

Dimzas N, Argyriou K, Zachou M, Kasti A, Petsis K, Lambrinou S Ann Gastroenterol. 2024; 37(2):182-190.

PMID: 38481784 PMC: 10927627. DOI: 10.20524/aog.2024.0864.


Risk Factors of Developing Postinfectious Irritable Bowel Syndrome in Shigellosis Patients, 5 Years After Hospitalization During the Outbreak.

Soheilipour M, Chahichi A, Mohajer H, Ghomashi N, Roohafza H, Adibi P Open Forum Infect Dis. 2024; 11(3):ofae032.

PMID: 38434613 PMC: 10906712. DOI: 10.1093/ofid/ofae032.


Irritable bowel syndrome (IBS) among Lebanese adults: unidentified IBS and associated factors.

Yazbeck G, Malaeb D, Shaaban H, Sarray El Dine A, Hallit S, Hallit R BMC Public Health. 2023; 23(1):1589.

PMID: 37605160 PMC: 10463955. DOI: 10.1186/s12889-023-16543-5.


Effects of a Low-FODMAP Diet on Irritable Bowel Syndrome in Both Children and Adults-A Narrative Review.

Morariu I, Avasilcai L, Vieriu M, Lupu V, Morariu B, Lupu A Nutrients. 2023; 15(10).

PMID: 37242178 PMC: 10223978. DOI: 10.3390/nu15102295.